THAILAND · MEDICAL DEVICES
Thailand Medical Device Standards 2026: The 21 Product Categories and the Standard for Each
Thailand has issued a new notification on medical device standards. The Notification of the Ministry of Public Health on Standards of Medical Devices that Manufacturers or Importers Must Comply With, B.E. 2569 (2026), replaces the 2020 notification and its three amendments. It was published in the Royal Gazette on 2 November 2026 and took effect on 3 November 2026.
The annex names 21 product categories and states which standard applies to each. If you manufacture or import any of them, this is the starting point for checking what your product must meet in Thailand. (Source: Thai FDA notification page)
What the notification replaces
The notification repeals four earlier ones on the same subject:
- the Standards notification B.E. 2563 (2020);
- the Standards notification (No. 2) B.E. 2563 (2020);
- the Standards notification (No. 3) B.E. 2563 (2020);
- the Standards notification (No. 4) B.E. 2567 (2024).
It is issued under Section 5, paragraph one, and Section 6(4) of the Medical Device Act B.E. 2551 (2008), on the advice of the Medical Device Committee.
Where a device-specific notification already sets the standard for a product, that notification applies (Clause 4).
The 21 product categories and the standard for each
For items 1 to 17, the annex does not set technical requirements itself. It points to an existing Ministry of Public Health notification for that product. The last column below shows what that notification, in turn, requires. For items 18 to 21, the annex lists the accepted standards directly.
| No. | Medical device | Notification named in the annex | What that notification points to |
|---|---|---|---|
| 1 | Surgical gloves | MOPH Notification (No. 31) B.E. 2547 (2004) | TIS 538; sterility under the USP sterility tests |
| 2 | Contact lenses | MOPH Notification, B.E. 2553 (2010) | Labelling, instructions-for-use warnings and reporting duties |
| 3 | Sterile single-use insulin syringes | MOPH Notification, B.E. 2553 (2010) | TIS 2084-2552 (U-40 and U-100 syringes) |
| 4 | Sterile single-use hypodermic syringes | MOPH Notification, B.E. 2553 (2010) | TIS 777-2552 |
| 5 | Examination gloves | MOPH Notification, B.E. 2555 (2012) | TIS 1056-2548 (rubber latex or rubber solution); ISO 11193-2 (PVC) |
| 6 | Condoms | MOPH Notification, B.E. 2556 (2013) | TIS 625-2554 (natural rubber latex); ISO 23409 (synthetic materials) |
| 7 | Ophthalmic viscosurgical devices (OVDs) | MOPH Notification, B.E. 2557 (2014) | ISO 15798:2010 |
| 8 | Urine methamphetamine test kits | MOPH Notification, B.E. 2556 (2013), and (No. 2) B.E. 2559 (2016) | Cut-off of not more than 1,000 ng/mL (as amended in 2016); labelling and instructions-for-use content |
| 9 | Human blood bags | MOPH Notification, B.E. 2559 (2016) | TIS 1298-2555 or ISO 3826 |
| 10 | Haemodialysis concentrates | MOPH Notification, B.E. 2560 (2017) | ISO 13958:2009 or ANSI/AAMI RD52:2004 |
| 11 | Tooth-whitening products | MOPH Notification designating tooth-whitening products as medical devices, B.E. 2561 (2018) | Scope defined by hydrogen peroxide and total fluoride concentrations; sale limited to the buyers named in the notification (dental facilities, dental practitioners and licensed medical device sellers) |
| 12 | HIV test kits | MOPH Notification, B.E. 2552 (2009), and (No. 2) B.E. 2562 (2019) | Performance criteria annexed to the notification (sensitivity, specificity, sample sizes) |
| 13 | HIV self-test screening kits | MOPH Notification, B.E. 2562 (2019) | Performance criteria annexed to the notification, for blood and oral fluid |
| 14 | Contact lens care products | MOPH Notification, B.E. 2562 (2019) | ISO 14534:2011 |
| 15 | Injectable hyaluronic acid for correcting skin defects | MOPH Notification, B.E. 2562 (2019) | Pharmacopoeial or equivalent international standard, with stability data |
| 16 | Alcohol-containing disinfection products for human, animal and medical-device use | MOPH Notification, B.E. 2562 (2019) | Pharmacopoeial standard, with microbiological and stability data |
| 17 | Silicone breast implants | MOPH Notification, B.E. 2562 (2019) | ISO 14607:2018 |
| 18 | Surgical gowns and isolation gowns | — | Standards listed in the annex |
| 19 | Medical coveralls | — | Standards listed in the annex |
| 20 | Single-use medical face masks | — | Standards listed in the annex |
| 21 | Single-use medical face masks, N95 or higher | — | Standards listed in the annex |
The last column is a summary. Most of these notifications also accept later editions or equivalent standards, and several add Thai labelling and sales conditions. Read the notification itself, and confirm the current edition of the standard, before planning tests. (Source: Thai FDA device-specific notifications)
For the accepted standards for items 18 to 21, see our separate guide: Thailand medical mask, N95 and gown standards.
IVD products on the list
Three of the 21 items are in vitro diagnostic products:
- urine methamphetamine test kits (item 8);
- HIV test kits (item 12);
- HIV self-test screening kits (item 13).
All three have Thailand-specific requirements set out in their own notifications. The HIV notifications carry annexes with minimum sensitivity and specificity and the number of samples required. The methamphetamine notification sets the cut-off. A technical file for these products should be checked against those documents, not against the 2026 notification alone.
Separately, the Thai FDA is consulting on the principles of a draft notification on quality standards for urine-based HIV screening test kits. The consultation runs from 21 October to 19 November 2026. It has not been finalised. (Source: Thai FDA consultation page)
Transition for existing products and pending applications
- Existing holders. Licence holders, detailed notification holders and listing holders who were already manufacturing or importing before the notification took effect, and who intend to continue, must comply with the standards within one year of 3 November 2026 (Clause 5). This is not a general grace period for new applicants.
- Products already on the market. Sellers may continue to sell these devices until they expire, or until the Secretary-General orders their sale to be suspended or stopped (Clause 5).
- Future revisions. When a standard in the annex is revised, manufacturers and importers operating before the revision may continue to use the previous version for up to one year from the date the revised standard takes effect (Clause 6).
- Pending applications. Applications for a licence, detailed notification or listing that were filed before the effective date and are still under review are treated as filed under this notification. The authority may ask for further documents or evidence (Clause 7).
What manufacturers should do now
- Check whether your product falls within one of the 21 categories.
- For items 1 to 17, obtain the notification named in the annex and check your product against it, including its labelling conditions.
- For items 18 to 21, confirm which listed standard your test reports follow, and which edition.
- If you were already manufacturing or importing under a Thai licence, detailed notification or listing, plan the work inside the one-year window.
Frequently asked questions
Does the notification apply to every medical device in Thailand?
No. It sets standards for the 21 product categories in its annex. Other devices remain subject to the registration requirements that apply to their risk class.
When did it take effect?
On 3 November 2026, the day after publication in the Royal Gazette.
Who gets the one-year transition?
Licence, detailed notification and listing holders who were already manufacturing or importing the product before 3 November 2026 and intend to continue. New applicants are assessed against the notification from the start.
Are applications filed before 3 November 2026 affected?
Yes. Pending applications are treated as filed under the new notification, and the authority may request additional documents.
Does the annex set the technical requirements for all 21 categories?
Only for items 18 to 21. For items 1 to 17 it refers to the existing notification for each product.
Which international standards are accepted for masks and gowns?
The annex lists US, European, Chinese and Thai routes as alternatives. See Thailand medical mask, N95 and gown standards.
Official references
- Thai FDA, Medical Device Control Division: Notification of the Ministry of Public Health on Standards of Medical Devices that Manufacturers or Importers Must Comply With, B.E. 2569 (2026). Signed 30 September 2026; Royal Gazette Vol. 143, Special Section 261 Ngor, pp. 20–21, 2 November 2026; effective 3 November 2026, https://medical.fda.moph.go.th/relevant-laws-and-standards/mdlaw135336
- Thai FDA, Medical Device Control Division: device-specific Ministry of Public Health notifications (items 1 to 17), https://medical.fda.moph.go.th/relevant-laws-and-standards/category/md-specifically-announced
- Thai FDA, Medical Device Control Division: Public consultation on the principles of the draft Thai FDA notification on quality standards for urine-based HIV screening test kits, 21 October – 19 November 2026, https://medical.fda.moph.go.th/relevant-laws-and-standards/hearing69-1
Prepared from official sources verifiable as of 4 November 2026 for general compliance planning; applicability must be confirmed against the product, the proposed scope and the regulator’s requirements.
